Entresto 24 MG-26 MG tablet 180S
Ended Awarded Last action
- Contract number
- SPE2DR26FB2QH
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,065
Award facts
- Contract value 100% obligated
- $14,065.43 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
On February 4, 2026, the Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Entresto 24 mg-26 mg tablets (180-count units) under a firm fixed-price contract valued at $14,065.43. This non-set-aside, competitively awarded delivery order is scheduled for ultimate completion on February 5, 2026, with performance taking place at the contractor's location in Conshohocken, Pennsylvania. The award represents a task order issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at up to $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and subsidiary of Cencora, Inc., which operates as the parent entity and primary government contractor. Both entities hold significant contracts with the DLA and other federal healthcare systems, including the Defense Health Agency and the Department of Veterans Affairs, supplying an extensive portfolio of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This delivery order for Entresto, a cardiovascular medication, exemplifies the company's ongoing role as a critical vendor supporting military and federal medical supply chains through competitively awarded, firm fixed-price transactions.
Quick answers
Who was awarded contract SPE2DR26FB2QH?
SPE2DR26FB2QH was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 4, 2026.
How much is contract SPE2DR26FB2QH worth?
The government has obligated $14,065 on SPE2DR26FB2QH.
Is contract SPE2DR26FB2QH an order under another contract?
Yes. SPE2DR26FB2QH is a delivery order under SPE2DR25D2102, an indefinite delivery contract.
Was contract SPE2DR26FB2QH competed?
The extent of competition for SPE2DR26FB2QH was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award